Last 12 months
Inside the activity.
3 purchase rows · 0 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 1 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 2 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 09, 2022 Filed Feb 9, 2022 17:10 UTC |
HRUSOVSKY E KEVINDirector · Chairman and CEO
|
SaleCommon Stock | 1,364 | $34.97 | $47,697.17 |
DisclosureSEC source: 0001562180-22-001270 · primarydocument.xml · nonDerivative · entry 1 HRUSOVSKY E KEVIN · CIK 0001252546 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 888,433 F1 · shares: The sales of shares reported on this Form 4 were made solely to cover tax obligations upon the vesting of 4,599 RSUs. F2 · price: This transaction was executed in multiple trades at prices ranging from $34.9435 to $34.985. The price reported reflects the weighted average sale price. The reporting person undertakes to provide upon request to the SEC staff, the issuer or any security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F3 · balance_after: Includes 43,350 restricted stock units. Read SEC document |
| February 09, 2022 Filed Feb 9, 2022 22:12 UTC |
Mattoon DawnSr. VP, Diagnostics
|
SaleCommon Stock | 318 | $34.97 | $11,120.01 |
DisclosureSEC source: 0001562180-22-001272 · primarydocument.xml · nonDerivative · entry 1 Mattoon Dawn · CIK 0001731785 · Sr. VP, Diagnostics 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,404 F1 · shares: The sales of shares reported on this Form 4 were made solely to cover tax obligations upon the vesting of 919 RSUs. F2 · price: This transaction was executed in multiple trades at prices ranging from $34.9435 to $34.985. The price reported reflects the weighted average sale price. The reporting person undertakes to provide upon request to the SEC staff, the issuer or any security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F3 · balance_after: Includes 10,785 restricted stock units. Read SEC document |
| February 09, 2022 Filed Feb 9, 2022 22:13 UTC |
Roskey Mark T.SVP, Strategic Partnerships
|
SaleCommon Stock | 292 | $34.97 | $10,210.83 |
DisclosureSEC source: 0001562180-22-001277 · primarydocument.xml · nonDerivative · entry 1 Roskey Mark T. · CIK 0001724565 · SVP, Strategic Partnerships 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,662 F1 · shares: The sales of shares reported on this Form 4 were made solely to cover tax obligations upon the vesting of 843 RSUs. F2 · price: This transaction was executed in multiple trades at prices ranging from $34.9435 to $34.985. The price reported reflects the weighted average sale price. The reporting person undertakes to provide upon request to the SEC staff, the issuer or any security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F3 · balance_after: Includes 9,146 restricted stock units. Read SEC document |
| February 04, 2022 Filed Feb 4, 2022 21:01 UTC |
Duffy David C.SVP R&D and CTO
|
SaleCommon Stock | 3,266 | $30.91 | $100,952.06 |
DisclosureSEC source: 0001562180-22-001138 · primarydocument.xml · nonDerivative · entry 1 Duffy David C. · CIK 0001724566 · SVP R&D and CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 57,996 F1 · shares: The sale of shares reported on this Form 4 was made pursuant to a Rule 10b5-1 trading plan adopted on November 16, 2021. F2 · balance_after: Includes 7,287 restricted stock units. Read SEC document |
| February 02, 2022 Filed Feb 4, 2022 16:00 UTC |
Fry John JGeneral Counsel & Secretary
|
SaleCommon Stock | 99 | $32.15 | $3,182.85 |
DisclosureSEC source: 0001562180-22-001134 · primarydocument.xml · nonDerivative · entry 2 Fry John J · CIK 0001419544 · General Counsel & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,605 F1 · shares: The sales of shares reported on this Form 4 were made solely to cover tax obligations upon the vesting of 700 RSUs. F3 · balance_after: Includes 16,770 restricted stock units. Read SEC document |
| February 02, 2022 Filed Feb 4, 2022 16:00 UTC |
Fry John JGeneral Counsel & Secretary
|
SaleCommon Stock | 272 | $31.21 | $8,488.20 |
DisclosureSEC source: 0001562180-22-001134 · primarydocument.xml · nonDerivative · entry 1 Fry John J · CIK 0001419544 · General Counsel & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,704 F1 · shares: The sales of shares reported on this Form 4 were made solely to cover tax obligations upon the vesting of 700 RSUs. F2 · price: This transaction was executed in multiple trades at prices ranging from $30.84 to $31.83. The price reported reflects the weighted average sale price. The reporting person undertakes to provide upon request to the SEC staff, the issuer or any security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F3 · balance_after: Includes 16,770 restricted stock units. Read SEC document |
| February 02, 2022 Filed Feb 4, 2022 16:00 UTC |
HRUSOVSKY E KEVINDirector · Chairman and CEO
|
SaleCommon Stock | 158 | $32.15 | $5,079.70 |
DisclosureSEC source: 0001562180-22-001135 · primarydocument.xml · nonDerivative · entry 2 HRUSOVSKY E KEVIN · CIK 0001252546 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 889,797 F1 · shares: The sales of shares reported on this Form 4 were made solely to cover tax obligations upon the vesting of 1,685 RSUs. F3 · balance_after: Includes 47,949 restricted stock units. Read SEC document |
| February 02, 2022 Filed Feb 4, 2022 16:00 UTC |
HRUSOVSKY E KEVINDirector · Chairman and CEO
|
SaleCommon Stock | 431 | $31.21 | $13,450.04 |
DisclosureSEC source: 0001562180-22-001135 · primarydocument.xml · nonDerivative · entry 1 HRUSOVSKY E KEVIN · CIK 0001252546 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 889,955 F1 · shares: The sales of shares reported on this Form 4 were made solely to cover tax obligations upon the vesting of 1,685 RSUs. F2 · price: This transaction was executed in multiple trades at prices ranging from $30.84 to $31.83. The price reported reflects the weighted average sale price. The reporting person undertakes to provide upon request to the SEC staff, the issuer or any security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F3 · balance_after: Includes 47,949 restricted stock units. Read SEC document |
| February 02, 2022 Filed Feb 4, 2022 21:01 UTC |
Roskey Mark T.SVP, Strategic Partnerships
|
SaleCommon Stock | 44 | $32.15 | $1,414.60 |
DisclosureSEC source: 0001562180-22-001137 · primarydocument.xml · nonDerivative · entry 2 Roskey Mark T. · CIK 0001724565 · SVP, Strategic Partnerships 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,954 F1 · shares: The sales of shares reported on this Form 4 were made solely to cover tax obligations upon the vesting of 472 RSUs. F3 · balance_after: Includes 9,989 restricted stock units. Read SEC document |
| February 02, 2022 Filed Feb 4, 2022 21:01 UTC |
Roskey Mark T.SVP, Strategic Partnerships
|
SaleCommon Stock | 122 | $31.21 | $3,807.21 |
DisclosureSEC source: 0001562180-22-001137 · primarydocument.xml · nonDerivative · entry 1 Roskey Mark T. · CIK 0001724565 · SVP, Strategic Partnerships 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,998 F1 · shares: The sales of shares reported on this Form 4 were made solely to cover tax obligations upon the vesting of 472 RSUs. F2 · price: This transaction was executed in multiple trades at prices ranging from $30.84 to $31.83. The price reported reflects the weighted average sale price. The reporting person undertakes to provide upon request to the SEC staff, the issuer or any security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F3 · balance_after: Includes 9,989 restricted stock units. Read SEC document |
| February 02, 2022 Filed Feb 4, 2022 21:00 UTC |
Mattoon DawnSr. VP, Diagnostics
|
SaleCommon Stock | 71 | $32.15 | $2,282.65 |
DisclosureSEC source: 0001562180-22-001136 · primarydocument.xml · nonDerivative · entry 2 Mattoon Dawn · CIK 0001731785 · Sr. VP, Diagnostics 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,722 F1 · shares: The sales of shares reported on this Form 4 were made solely to cover tax obligations upon the vesting of 762 RSUs. F3 · balance_after: Includes 11,704 restricted stock units. Read SEC document |
| February 02, 2022 Filed Feb 4, 2022 21:00 UTC |
Mattoon DawnSr. VP, Diagnostics
|
SaleCommon Stock | 196 | $31.21 | $6,116.49 |
DisclosureSEC source: 0001562180-22-001136 · primarydocument.xml · nonDerivative · entry 1 Mattoon Dawn · CIK 0001731785 · Sr. VP, Diagnostics 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,793 F1 · shares: The sales of shares reported on this Form 4 were made solely to cover tax obligations upon the vesting of 762 RSUs. F2 · price: This transaction was executed in multiple trades at prices ranging from $30.84 to $31.83. The price reported reflects the weighted average sale price. The reporting person undertakes to provide upon request to the SEC staff, the issuer or any security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F3 · balance_after: Includes 11,704 restricted stock units. Read SEC document |
| January 31, 2022 Filed Jan 31, 2022 21:12 UTC |
Duffy David C.SVP R&D and CTO
|
SaleCommon Stock | 3,266 | $30.00 | $97,980.00 |
DisclosureSEC source: 0001562180-22-000795 · primarydocument.xml · nonDerivative · entry 1 Duffy David C. · CIK 0001724566 · SVP R&D and CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 61,262 F1 · shares: The sale of shares reported on this Form 4 was made pursuant to a Rule 10b5-1 trading plan adopted on November 16, 2021. F2 · balance_after: Includes 7,653 restricted stock units. Read SEC document |
| January 03, 2022 Filed Jan 5, 2022 21:05 UTC |
MEISTER PAUL MDirector
|
GrantStock Option (Right to Buy) · Derivative | 4,002 | $0.00 Strike: $42.41 | $0.00 |
DisclosureSEC source: 0001562180-22-000225 · primarydocument.xml · derivative · entry 3 MEISTER PAUL M · CIK 0001033876 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,002 Underlying: Common Stock · 4,002 shares Expires 2032-01-03 F5 · shares: Represents non-qualified stock option to purchase 4,002 shares of common stock granted pursuant to the Quanterix Corporation 2018 Non-Employee Director Compensation Policy. Read SEC document |
| January 03, 2022 Filed Jan 5, 2022 21:05 UTC |
MEISTER PAUL MDirector
|
GrantCommon Stock | 324 | $42.41 | $13,740.84 |
DisclosureSEC source: 0001562180-22-000225 · primarydocument.xml · nonDerivative · entry 2 MEISTER PAUL M · CIK 0001033876 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,922 F3 · shares: Consists of stock granted in lieu of cash fees for service on the Company's Board of Directors and committees thereof for the fourth quarter of 2021. F4 · price: Closing price of the Company's common stock on the Nasdaq Global Market on January 3, 2022. F2 · balance_after: Includes 2,668 restricted stock units. Read SEC document |
| January 03, 2022 Filed Jan 5, 2022 21:05 UTC |
MEISTER PAUL MDirector
|
GrantCommon Stock | 2,668 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-22-000225 · primarydocument.xml · nonDerivative · entry 1 MEISTER PAUL M · CIK 0001033876 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,598 F1 · shares: Represents restricted stock units that vest as to 100% of the shares on December 31, 2022 granted pursuant to the Quanterix Corporation 2018 Non-Employee Director Compensation Policy. Each restricted stock unit represents the right to receive one share of the Issuer's common stock. F2 · balance_after: Includes 2,668 restricted stock units. Read SEC document |
| January 03, 2022 Filed Jan 5, 2022 16:05 UTC |
Hlavinka Sarah E.Director
|
GrantStock Option (Right to Buy) · Derivative | 4,002 | $0.00 Strike: $42.41 | $0.00 |
DisclosureSEC source: 0001562180-22-000226 · primarydocument.xml · derivative · entry 3 Hlavinka Sarah E. · CIK 0001433554 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,002 Underlying: Common Stock · 4,002 shares Expires 2032-01-03 F5 · shares: Represents non-qualified stock option to purchase 4,002 shares of common stock granted pursuant to the Quanterix Corporation 2018 Non-Employee Director Compensation Policy. Read SEC document |
| January 03, 2022 Filed Jan 5, 2022 16:05 UTC |
Hlavinka Sarah E.Director
|
GrantCommon Stock | 280 | $42.41 | $11,874.80 |
DisclosureSEC source: 0001562180-22-000226 · primarydocument.xml · nonDerivative · entry 2 Hlavinka Sarah E. · CIK 0001433554 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,840 F3 · shares: Consists of stock granted in lieu of cash fees for service on the Company's Board of Directors and committees thereof for the fourth quarter of 2021. F4 · price: Closing price of the Company's common stock on the Nasdaq Global Market on January 3, 2022. F2 · balance_after: Includes 2,668 restricted stock units. Read SEC document |
| January 03, 2022 Filed Jan 5, 2022 16:05 UTC |
Hlavinka Sarah E.Director
|
GrantCommon Stock | 2,668 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-22-000226 · primarydocument.xml · nonDerivative · entry 1 Hlavinka Sarah E. · CIK 0001433554 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,560 F1 · shares: Represents restricted stock units that vest as to 100% of the shares on December 31, 2022 granted pursuant to the Quanterix Corporation 2018 Non-Employee Director Compensation Policy. Each restricted stock unit represents the right to receive one share of the Issuer's common stock. F2 · balance_after: Includes 2,668 restricted stock units. Read SEC document |
| January 03, 2022 Filed Jan 5, 2022 16:06 UTC |
Fry John JGeneral Counsel & Secretary
|
SaleCommon Stock | 352 | $41.91 | $14,751.12 |
DisclosureSEC source: 0001562180-22-000230 · primarydocument.xml · nonDerivative · entry 1 Fry John J · CIK 0001419544 · General Counsel & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,976 F1 · shares: The sales of shares reported on this Form 4 were made solely to cover tax obligations upon the vesting of 700 RSUs. F2 · price: This transaction was executed in multiple trades at prices ranging from $41.71 to $42.16. The price reported reflects the weighted average sale price. The reporting person undertakes to provide upon request to the SEC staff, the issuer or any security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F3 · balance_after: Includes 17,470 restricted stock units. Read SEC document |
| January 03, 2022 Filed Jan 5, 2022 21:06 UTC |
Madaus Martin DDirector
|
GrantStock Option (Right to Buy) · Derivative | 4,002 | $0.00 Strike: $42.41 | $0.00 |
DisclosureSEC source: 0001562180-22-000231 · primarydocument.xml · derivative · entry 4 Madaus Martin D · CIK 0001310268 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,002 Underlying: Common Stock · 4,002 shares Expires 2032-01-03 F6 · shares: Represents non-qualified stock option to purchase 4,002 shares of common stock granted pursuant to the Quanterix Corporation 2018 Non-Employee Director Compensation Policy. Read SEC document |
| January 03, 2022 Filed Jan 5, 2022 21:06 UTC |
Madaus Martin DDirector
|
GrantCommon Stock | 427 | $42.41 | $18,109.07 |
DisclosureSEC source: 0001562180-22-000231 · primarydocument.xml · nonDerivative · entry 2 Madaus Martin D · CIK 0001310268 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,443 F3 · shares: Consists of stock granted in lieu of cash fees for service on the Company's Board of Directors and committees thereof for the fourth quarter of 2021. F4 · price: Closing price of the Company's common stock on the Nasdaq Global Market on January 3, 2022. F2 · balance_after: Includes 2,668 restricted stock units. Read SEC document |
| January 03, 2022 Filed Jan 5, 2022 21:06 UTC |
Madaus Martin DDirector
|
GrantCommon Stock | 2,668 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-22-000231 · primarydocument.xml · nonDerivative · entry 1 Madaus Martin D · CIK 0001310268 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,016 F1 · shares: Represents restricted stock units that vest as to 100% of the shares on December 31, 2022 granted pursuant to the Quanterix Corporation 2018 Non-Employee Director Compensation Policy. Each restricted stock unit represents the right to receive one share of the Issuer's common stock. F2 · balance_after: Includes 2,668 restricted stock units. Read SEC document |
| January 03, 2022 Filed Jan 5, 2022 16:05 UTC |
WALT DAVID RDirector
|
GrantStock Option (Right to Buy) · Derivative | 4,002 | $0.00 Strike: $42.41 | $0.00 |
DisclosureSEC source: 0001562180-22-000223 · primarydocument.xml · derivative · entry 2 WALT DAVID R · CIK 0001205236 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,002 Underlying: Common Stock · 4,002 shares Expires 2032-01-03 F3 · shares: Represents non-qualified stock option to purchase 4,002 shares of common stock granted pursuant to the Quanterix Corporation 2018 Non-Employee Director Compensation Policy. Read SEC document |
| January 03, 2022 Filed Jan 5, 2022 16:05 UTC |
WALT DAVID RDirector
|
GrantCommon Stock | 2,668 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-22-000223 · primarydocument.xml · nonDerivative · entry 1 WALT DAVID R · CIK 0001205236 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,281,312 F1 · shares: Represents restricted stock units that vest as to 100% of the shares on December 31, 2022 granted pursuant to the Quanterix Corporation 2018 Non-Employee Director Compensation Policy. Each restricted stock unit represents the right to receive one share of the Issuer's common stock. F2 · balance_after: Includes 2,668 restricted stock units. Read SEC document |
| January 03, 2022 Filed Jan 5, 2022 21:06 UTC |
CRANDELL KEITHDirector · 10% owner
|
GrantStock Option (Right to Buy) · Derivative | 4,002 | $0.00 Strike: $42.41 | $0.00 |
DisclosureSEC source: 0001562180-22-000232 · primarydocument.xml · derivative · entry 9 CRANDELL KEITH · CIK 0001219039 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,002 Underlying: Common Stock · 4,002 shares Expires 2032-01-03 F9 · shares: Represents non-qualified stock option to purchase 4,002 shares of common stock granted pursuant to the Quanterix Corporation 2018 Non-Employee Director Compensation Policy. Read SEC document |
| January 03, 2022 Filed Jan 5, 2022 21:06 UTC |
CRANDELL KEITHDirector · 10% owner
|
GrantCommon Stock | 307 | $42.41 | $13,019.87 |
DisclosureSEC source: 0001562180-22-000232 · primarydocument.xml · nonDerivative · entry 8 CRANDELL KEITH · CIK 0001219039 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 118,257 F7 · shares: Consists of stock granted in lieu of cash fees for service on the Company's Board of Directors and committees thereof for the fourth quarter of 2021. F8 · price: Closing price of the Company's common stock on the Nasdaq Global Market on January 3, 2021. F6 · balance_after: Includes 2,668 restricted stock units. Read SEC document |
| January 03, 2022 Filed Jan 5, 2022 21:06 UTC |
CRANDELL KEITHDirector · 10% owner
|
GrantCommon Stock | 2,668 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-22-000232 · primarydocument.xml · nonDerivative · entry 7 CRANDELL KEITH · CIK 0001219039 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 117,950 F5 · shares: Represents restricted stock units that vest as to 100% of the shares on December 31, 2022 granted pursuant to the Quanterix Corporation 2018 Non-Employee Director Compensation Policy. Each restricted stock unit represents the right to receive one share of the Issuer's common stock. F6 · balance_after: Includes 2,668 restricted stock units. Read SEC document |
| January 03, 2022 Filed Jan 5, 2022 16:06 UTC |
HRUSOVSKY E KEVINDirector · Chairman and CEO
|
SaleCommon Stock | 3,715 | $41.91 | $155,683.02 |
DisclosureSEC source: 0001562180-22-000229 · primarydocument.xml · nonDerivative · entry 1 HRUSOVSKY E KEVIN · CIK 0001252546 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 890,386 F1 · shares: The sales of shares reported on this Form 4 were made solely to cover tax obligations upon the vesting of 7,935 RSUs. F2 · price: This transaction was executed in multiple trades at prices ranging from $41.71 to $42.16. The price reported reflects the weighted average sale price. The reporting person undertakes to provide upon request to the SEC staff, the issuer or any security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F3 · balance_after: Includes 49,634 restricted stock units. Read SEC document |
| January 03, 2022 Filed Jan 5, 2022 21:05 UTC |
OLSON LAURIE JDirector
|
GrantStock Option (Right to Buy) · Derivative | 4,002 | $0.00 Strike: $42.41 | $0.00 |
DisclosureSEC source: 0001562180-22-000224 · primarydocument.xml · derivative · entry 2 OLSON LAURIE J · CIK 0001553231 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,002 Underlying: Common Stock · 4,002 shares Expires 2032-01-03 F3 · shares: Represents non-qualified stock option to purchase 4,002 shares of common stock granted pursuant to the Quanterix Corporation 2018 Non-Employee Director Compensation Policy. Read SEC document |
| January 03, 2022 Filed Jan 5, 2022 21:05 UTC |
OLSON LAURIE JDirector
|
GrantCommon Stock | 2,668 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-22-000224 · primarydocument.xml · nonDerivative · entry 1 OLSON LAURIE J · CIK 0001553231 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,208 F1 · shares: Represents restricted stock units that vest as to 100% of the shares on December 31, 2022 granted pursuant to the Quanterix Corporation 2018 Non-Employee Director Compensation Policy. Each restricted stock unit represents the right to receive one share of the Issuer's common stock. F2 · balance_after: Includes 7,208 restricted stock units. Read SEC document |
| January 03, 2022 Filed Jan 5, 2022 21:06 UTC |
Roskey Mark T.SVP, Strategic Partnerships
|
SaleCommon Stock | 149 | $41.91 | $6,244.08 |
DisclosureSEC source: 0001562180-22-000228 · primarydocument.xml · nonDerivative · entry 1 Roskey Mark T. · CIK 0001724565 · SVP, Strategic Partnerships 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,120 F1 · shares: The sales of shares reported on this Form 4 were made solely to cover tax obligations upon the vesting of 472 RSUs. F2 · price: This transaction was executed in multiple trades at prices ranging from $41.71 to $42.16. The price reported reflects the weighted average sale price. The reporting person undertakes to provide upon request to the SEC staff, the issuer or any security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F3 · balance_after: Includes 10,461 restricted stock units. Read SEC document |
| January 03, 2022 Filed Jan 5, 2022 21:06 UTC |
Mattoon DawnSr. VP, Diagnostics
|
SaleCommon Stock | 355 | $41.91 | $14,876.84 |
DisclosureSEC source: 0001562180-22-000227 · primarydocument.xml · nonDerivative · entry 1 Mattoon Dawn · CIK 0001731785 · Sr. VP, Diagnostics 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,989 F1 · shares: The sales of shares reported on this Form 4 were made solely to cover tax obligations upon the vesting of 750 RSUs. F2 · price: This transaction was executed in multiple trades at prices ranging from $41.71 to $42.16. The price reported reflects the weighted average sale price. The reporting person undertakes to provide upon request to the SEC staff, the issuer or any security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F3 · balance_after: Includes 12,466 restricted stock units. Read SEC document |
| January 03, 2022 Filed Jan 5, 2022 21:04 UTC |
Duffy David C.SVP R&D and CTO
|
Exercise / conversionStock Option (Right to buy) · Derivative | 21,023 | $0.00 Strike: $2.28 | $0.00 |
DisclosureSEC source: 0001562180-22-000222 · primarydocument.xml · derivative · entry 6 Duffy David C. · CIK 0001724566 · SVP R&D and CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 21,023 shares Expires 2022-02-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: All shares underlying this option have vested. Read SEC document |
| January 03, 2022 Filed Jan 5, 2022 21:04 UTC |
Duffy David C.SVP R&D and CTO
|
Exercise / conversionStock Option (right to buy) · Derivative | 15,556 | $0.00 Strike: $2.89 | $0.00 |
DisclosureSEC source: 0001562180-22-000222 · primarydocument.xml · derivative · entry 5 Duffy David C. · CIK 0001724566 · SVP R&D and CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 15,556 shares Expires 2023-05-21 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: All shares underlying this option have vested. Read SEC document |
| January 03, 2022 Filed Jan 5, 2022 21:04 UTC |
Duffy David C.SVP R&D and CTO
|
Exercise / conversionStock Option (right to buy) · Derivative | 4,667 | $0.00 Strike: $2.96 | $0.00 |
DisclosureSEC source: 0001562180-22-000222 · primarydocument.xml · derivative · entry 4 Duffy David C. · CIK 0001724566 · SVP R&D and CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 4,667 shares Expires 2024-07-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: All shares underlying this option have vested. Read SEC document |
| January 03, 2022 Filed Jan 5, 2022 21:04 UTC |
Duffy David C.SVP R&D and CTO
|
Exercise / conversionCommon Stock | 21,023 | $2.28 | $47,932.44 |
DisclosureSEC source: 0001562180-22-000222 · primarydocument.xml · nonDerivative · entry 3 Duffy David C. · CIK 0001724566 · SVP R&D and CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 64,528 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 7,653 restricted stock units. Read SEC document |
| January 03, 2022 Filed Jan 5, 2022 21:04 UTC |
Duffy David C.SVP R&D and CTO
|
Exercise / conversionCommon Stock | 15,556 | $2.89 | $44,956.84 |
DisclosureSEC source: 0001562180-22-000222 · primarydocument.xml · nonDerivative · entry 2 Duffy David C. · CIK 0001724566 · SVP R&D and CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,505 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 03, 2022 Filed Jan 5, 2022 21:04 UTC |
Duffy David C.SVP R&D and CTO
|
Exercise / conversionCommon Stock | 4,667 | $2.96 | $13,814.32 |
DisclosureSEC source: 0001562180-22-000222 · primarydocument.xml · nonDerivative · entry 1 Duffy David C. · CIK 0001724566 · SVP R&D and CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,949 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 29, 2021 Filed Dec 30, 2021 21:57 UTC |
Duffy David C.SVP R&D and CTO
|
SaleCommon Stock | 1,667 | $40.71 | $67,863.57 |
DisclosureSEC source: 0001562180-21-007919 · primarydocument.xml · nonDerivative · entry 1 Duffy David C. · CIK 0001724566 · SVP R&D and CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,282 F1 · shares: The sale of shares reported on this Form 4 was made pursuant to a Rule 10b5-1 trading plan adopted on March 8, 2021. F2 · balance_after: Includes 8,019 restricted stock units. Read SEC document |
| December 01, 2021 Filed Dec 3, 2021 16:18 UTC |
Fry John JGeneral Counsel & Secretary
|
SaleCommon Stock | 12 | $41.00 | $492.00 |
DisclosureSEC source: 0001562180-21-007438 · primarydocument.xml · nonDerivative · entry 2 Fry John J · CIK 0001419544 · General Counsel & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,328 F1 · shares: The sales of shares reported on this Form 4 were made solely to cover tax obligations upon the vesting of 700 RSUs. Read SEC document |
| December 01, 2021 Filed Dec 3, 2021 16:18 UTC |
Fry John JGeneral Counsel & Secretary
|
SaleCommon Stock | 338 | $40.26 | $13,609.33 |
DisclosureSEC source: 0001562180-21-007438 · primarydocument.xml · nonDerivative · entry 1 Fry John J · CIK 0001419544 · General Counsel & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,340 F1 · shares: The sales of shares reported on this Form 4 were made solely to cover tax obligations upon the vesting of 700 RSUs. F2 · price: This transaction was executed in multiple trades at prices ranging from $40.00 to $40.92. The price reported reflects the weighted average sale price. The reporting person undertakes to provide upon request to the SEC staff, the issuer or any security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F3 · balance_after: Includes 18,170 restricted stock units. Read SEC document |
| December 01, 2021 Filed Dec 3, 2021 16:20 UTC |
HRUSOVSKY E KEVINDirector · Chairman and CEO
|
SaleCommon Stock | 131 | $41.00 | $5,371.00 |
DisclosureSEC source: 0001562180-21-007443 · primarydocument.xml · nonDerivative · entry 2 HRUSOVSKY E KEVIN · CIK 0001252546 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 894,101 F1 · shares: The sales of shares reported on this Form 4 were made solely to cover tax obligations upon the vesting of 7,935 RSUs. Read SEC document |
| December 01, 2021 Filed Dec 3, 2021 16:20 UTC |
HRUSOVSKY E KEVINDirector · Chairman and CEO
|
SaleCommon Stock | 3,579 | $40.26 | $144,105.93 |
DisclosureSEC source: 0001562180-21-007443 · primarydocument.xml · nonDerivative · entry 1 HRUSOVSKY E KEVIN · CIK 0001252546 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 894,232 F1 · shares: The sales of shares reported on this Form 4 were made solely to cover tax obligations upon the vesting of 7,935 RSUs. F2 · price: This transaction was executed in multiple trades at prices ranging from $40.00 to $40.92. The price reported reflects the weighted average sale price. The reporting person undertakes to provide upon request to the SEC staff, the issuer or any security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F3 · balance_after: Includes 57,569 restricted stock units. Read SEC document |
| December 01, 2021 Filed Dec 3, 2021 21:19 UTC |
Roskey Mark T.SVP, Strategic Partnerships
|
SaleCommon Stock | 5 | $41.00 | $205.00 |
DisclosureSEC source: 0001562180-21-007440 · primarydocument.xml · nonDerivative · entry 2 Roskey Mark T. · CIK 0001724565 · SVP, Strategic Partnerships 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,269 F1 · shares: The sales of shares reported on this Form 4 were made solely to cover tax obligations upon the vesting of 472 RSUs. Read SEC document |
| December 01, 2021 Filed Dec 3, 2021 21:19 UTC |
Roskey Mark T.SVP, Strategic Partnerships
|
SaleCommon Stock | 142 | $40.26 | $5,717.53 |
DisclosureSEC source: 0001562180-21-007440 · primarydocument.xml · nonDerivative · entry 1 Roskey Mark T. · CIK 0001724565 · SVP, Strategic Partnerships 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,274 F1 · shares: The sales of shares reported on this Form 4 were made solely to cover tax obligations upon the vesting of 472 RSUs. F2 · price: This transaction was executed in multiple trades at prices ranging from $40.00 to $40.92. The price reported reflects the weighted average sale price. The reporting person undertakes to provide upon request to the SEC staff, the issuer or any security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F3 · balance_after: Includes 10,933 restricted stock units. Read SEC document |
| December 01, 2021 Filed Dec 3, 2021 21:18 UTC |
Mattoon DawnSr. VP, Diagnostics
|
SaleCommon Stock | 12 | $41.00 | $492.00 |
DisclosureSEC source: 0001562180-21-007439 · primarydocument.xml · nonDerivative · entry 2 Mattoon Dawn · CIK 0001731785 · Sr. VP, Diagnostics 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,344 F1 · shares: The sales of shares reported on this Form 4 were made solely to cover tax obligations upon the vesting of 750 RSUs. Read SEC document |
| December 01, 2021 Filed Dec 3, 2021 21:18 UTC |
Mattoon DawnSr. VP, Diagnostics
|
SaleCommon Stock | 341 | $40.26 | $13,730.13 |
DisclosureSEC source: 0001562180-21-007439 · primarydocument.xml · nonDerivative · entry 1 Mattoon Dawn · CIK 0001731785 · Sr. VP, Diagnostics 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,356 F1 · shares: The sales of shares reported on this Form 4 were made solely to cover tax obligations upon the vesting of 750 RSUs. F2 · price: This transaction was executed in multiple trades at prices ranging from $40.00 to $40.92. The price reported reflects the weighted average sale price. The reporting person undertakes to provide upon request to the SEC staff, the issuer or any security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F3 · balance_after: Includes 13,216 restricted stock units. Read SEC document |
| November 19, 2021 Filed Nov 22, 2021 23:18 UTC |
Duffy David C.SVP R&D and CTO
|
SaleCommon Stock | 1,667 | $45.54 | $75,915.18 |
DisclosureSEC source: 0001562180-21-007206 · primarydocument.xml · nonDerivative · entry 1 Duffy David C. · CIK 0001724566 · SVP R&D and CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,949 F1 · shares: The sale of shares reported on this Form 4 was made pursuant to a Rule 10b5-1 trading plan adopted on March 8, 2021. F2 · balance_after: Includes 9,117 restricted stock units. Read SEC document |
| November 18, 2021 Filed Jan 5, 2022 21:06 UTC |
CRANDELL KEITHDirector · 10% owner
|
OtherCommon Stock | 9,318 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-22-000232 · primarydocument.xml · nonDerivative · entry 6 CRANDELL KEITH · CIK 0001219039 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 115,282 F1 · kind: Distribution of Common Stock held by a limited partnership to its partners for no consideration. F4 · kind: Change from indirect to direct ownership of shares previously reported as beneficially owned by the Reporting Person. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.